LEWIS H BENDER
CIK 1238705 · President and CEO · last filed 2026-03-30
LEWIS H BENDER is a President and CEO who has filed 14 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider was granted $230.6K of INTS on Mar 30, 2026. Across all open-market trades the lifetime net is +$24.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $721.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$721.8K
3
14
$24.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INTS | President and CEO | 118,549 | $3.62 | $429.1K | $0 | 3 | 2026-03-30 |
| INTERLEUKIN GENETICS INC (ILI) Delisted | CHIEF EXECUTIVE OFFICE | 201,136 | — | — | $24.2K | 6 | 2010-01-22 |
| EMIS | Chief Technology Officer | 28,833 | $10.15 | $292.7K | $0 | 4 | 2007-08-13 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-30 | INTS | Grant (A) | +37,749 | $230.6K | EDGAR |
| 2025-05-06 | INTS | Grant (A) | — | $0 | EDGAR |
| 2024-03-07 | INTS | Grant (A) | — | $0 | EDGAR |
| 2011-02-16 | — | Grant (A) | — | $0 | |
| 2010-01-22 | INTERLEUKIN GENETICS INC (ILI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-03-16 | INTERLEUKIN GENETICS INC (ILI) Delisted | Grant (A) | +110,000 | $29.7K | EDGAR |
| 2008-11-24 | INTERLEUKIN GENETICS INC (ILI) Delisted | Buy (P) | +30,000 | $7.7K | EDGAR |
| 2008-11-20 | INTERLEUKIN GENETICS INC (ILI) Delisted | Buy (P) | +30,000 | $12.3K | EDGAR |
| 2008-02-20 | INTERLEUKIN GENETICS INC (ILI) Delisted | Buy (P) | +3,000 | $4.2K | EDGAR |
| 2008-01-29 | INTERLEUKIN GENETICS INC (ILI) Delisted | Grant (A) | — | $0 | EDGAR |